Trade Winds Ventures Inc

Published : September 17th, 2015

Bedrocan Canada and Tweed announce multi-centre longitudinal surveillance study of medical cannabis patients

( 0 vote, 0/5 ) Print article
  Article Comments Comment this article Rating Follow Company  
0
Send
0
comment
Keywords :   Canada | Netherlands | Pharmaceutical | Privacy |

Bedrocan Canada and Tweed announce multi-centre longitudinal surveillance study of medical cannabis patients

EQUAL (Evaluation QUAlity of Life) Clinical Research Initiative Will Gather Anonymized Patient Data on Effects of Medical Cannabis

TORONTO , Sept. 17, 2015 /CNW/ - Bedrocan Canada Inc. ("Bedrocan" or the "Company"), a subsidiary of Tweed Marijuana Inc. (TWD.V) ("TMI" or "Tweed"), along with its sister company Tweed Inc., is pleased to announce the launch of the EQUAL (Evaluation QUAlity of Life) study. The clinical research initiative is a multi-centre, non-interventional, un-blinded study to evaluate quality of life in Canadian patients treated with medical cannabis. The company-sponsored study will evaluate patients who use Bedrocan and Tweed strains of cannabis to help manage symptoms of a range of chronic health conditions, and the resulting data will be submitted for publication by a peer-reviewed medical journal. To ensure patient privacy, all data collected will be anonymized and stored in a secure electronic database.

The primary objective of the study, which is intended to continue for three years, include more than 50 sites, and enroll up to 6,000 patients, is to evaluate the quality of life (QoL) of patients before and after treatment with medical cannabis. The study will use a well-established general QoL assessment instrument, the SF-36, and will record both positive and negative effects attributed to treatment.

The study will include patients registered under Health Canada's Marijuana for Medical Purposes Regulations (MMPR), who use Bedrocan and Tweed strains, and who volunteer to participate. Patients will be compensated for their participation via discounted cost of product used during the period of the study (12 months per patient), and clinical sites participating in the study will receive a nominal fee for the time required to complete and submit subject surveys of a patient.

The study will not include patients from Quebec , for whom a separate, independent research study was launched in May, 2015, as part of the Quebec Cannabis Registry. Bedrocan and Tweed, along with another licensed producer, are supporting the launch of the Quebec Registry via funding provided to the Canadian Consortium for the Investigation of Cannabinoids (CCIC), and the CCIC has provided a grant to the Research Institute of the McGill University Health Centre (RI-MUHC), to support the first year of the Registry's operations.

"This will be one of the world's largest studies on the therapeutic effects of medical cannabis, and will generate extremely valuable patient-level data on treatment benefits, risks and side effects," said Marc Wayne , President of Bedrocan Canada. "Tens of thousands of Canadian patients are currently using cannabis to manage symptoms from conditions ranging from chronic pain, to certain mental illnesses, multiple sclerosis, arthritis, spinal cord injury, HIV/AIDS, intractable forms of epilepsy and other conditions. We are launching this study to advance the science associated with medical cannabis, to provide the medical community with useful insights into its effect on quality of life, and to gather data specific to the effects of Bedrocan and Tweed strains in patients who use our products."

The principal investigator for the study is Dr. Martin A. Katzman , Director of the START (Stress, Trauma, Anxiety, Rehabilitation and Treatment) Clinic for Mood and Anxiety Disorders, and on faculty at both the Faculty of Medicine, University of Toronto as well as the Northern Ontario School of Medicine (NOSM). Dr. Katzman is also Chair of the Scientific Advisory Board of the Anxiety Disorders Association of Canada and a member of Bedrocan Canada's Medical Advisory Board.

"As the number of patients using medical cannabis increases, we have an urgent need to add to the body of literature and compile real-world data on who is using medical cannabis, how patients respond to prescribed cannabis, and what it can and cannot achieve as a treatment option," said Dr. Katzman. "No one in the medical community is recommending medical cannabis as a first-line therapy, but we know it is being used increasingly by patients refractory to conventional prescription drugs, or who cannot tolerate the side effects of conventional therapies. This study will provide the medical community with data we need, to understand how medical cannabis affects quality of life in patients with a number of different diagnoses and treatment regimens."

The clinical study will be launching with an initial three sites in Ontario and British Columbia : Wellmedica in Woodbridge, Ontario , Greendot Medical Clinic in Brantford, Ontario , and Greenleaf Medical Clinic in Abbotsford, British Columbia . Physicians and clinics who are interested in supporting this option for their patients and would like to contribute to the growing body of evidence for the appropriate therapeutic use of cannabis are encouraged to contact EQUAL@bedrocan.ca or EQUAL@tweed.com for more information.

DSG, Inc., a leading clinical data capture and management company based in Malvern, Pennsylvania , will provide their flagship eCaseLink™ electronic data capture (EDC) and Electronic Patient Reported Outcomes (ePRO) services for the study.

About Bedrocan

Bedrocan Canada is focused on clinical research, technologically-advanced, automated production processes, innovative product development, and environmentally responsible production and operation. The Company produces six strains of medical cannabis, and has two facilities in the Greater Toronto Area licensed by Health Canada under the Marihuana for Medical Purposes Regulations. Bedrocan Canada and its licensor Bedrocan Beheer BV ( Netherlands ) are the only companies in the world currently capable of producing standardized full-bud, pharmaceutical-grade medicinal cannabis. www.bedrocan.ca

About Tweed Marijuana Inc.

Tweed Marijuana Inc. is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with a total of four licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Tweed Farms, and Bedrocan Canada, the Company operates three state-of-the-art production facilities in Ontario, and distributes marijuana across the country to Canadian patients managing a host of medical conditions. The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, and furthering the public's understanding of how marijuana is used for medical purposes. www.tweed.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Bedrocan Cannabis Corp

Read the rest of the article at finance.yahoo.com
Data and Statistics for these countries : Canada | Netherlands | All
Gold and Silver Prices for these countries : Canada | Netherlands | All

Trade Winds Ventures Inc

EXPLORATION STAGE
CODE : TWD.V
Follow and Invest
Add to watch list Add to your portfolio Add or edit a note
Add Alert Add to Watchlists Add to Portfolio Add Note
ProfileMarket
Indicators
VALUE :
Projects & res.
Press
releases
Annual
report
RISK :
Asset profile
Contact Cpy

Trade Winds is a gold and copper exploration company based in Canada.

Trade Winds holds various exploration projects in Canada and in China.

Its main exploration properties are DETOUR LAKE, BIRCH LAKE, GOWEST, TURNER LAKE PROPERTY, TREASURE MOUNTAIN, BLOCK A and DARDANELLES in Canada and SILU and TUOLE in China.

Trade Winds is listed in Canada and in United States of America. Its market capitalisation is CA$ 168.8 millions as of today (US$ 127.4 millions, € 113.7 millions).

Its stock quote reached its lowest recent point on October 24, 2008 at CA$ 0.01, and its highest recent level on April 04, 2014 at CA$ 4.75.

Trade Winds has 93 240 000 shares outstanding.

Your feedback is appreciated, please leave a comment or rate this article.
Rate : Average note :0 (0 vote) View Top rated
 
Annual reports of Trade Winds Ventures Inc
2007 Annual Report
Project news of Trade Winds Ventures Inc
8/22/2011(Block A)Intersects 3.08 g/t gold over 20.8 metres on Block A
7/14/2011(Block A)Intersects 4.18 g/t gold over 18.4 metres on Block A
5/5/2011(Block A)Trade Winds Ventures Completes Preliminary Metallurgical St...
3/31/2011(Block A)Announces Initial Results of 2011 Drilling on Block A
2/16/2011(Block A)Files Updated NI 43-101 Technical Report for Block A on SED...
2/3/2011(Block A)Reports Assays from Previously Unsampled Core from its Drill...
7/7/2010(Block A)Announces Preliminary Metallurgical Study
1/19/2010(Block A)Begins 2010 Drill Program on Block ARecieved:
12/15/2009(Block A) Plans 2010 Drilling On Block A Recieved:
5/28/2009(Block A)Completes Updated Mineral Resource EstimateRecieved:
5/27/2009(Detour Lake)Executes Joint Venture With Detour GoldRecieved:
9/19/2008Files NI 43-101 Report for Silu Lead-Zinc Property in China
7/22/2008(Detour Lake)Proceeds with NI 43-101
10/2/2007Intersects High Grade Gold, 120.83 grams/tonne over 1.50 met...
Corporate news of Trade Winds Ventures Inc
9/22/2015BEDROCAN CANADA AND TWEED ANNOUNCE MULTI-CENTRE LONGITUDINAL...
9/17/2015Bedrocan Canada and Tweed announce multi-centre longitudinal...
9/15/2015Tweed Looks to Control Nearly Half of Canadian Cannabis Mark...
9/4/2015Tweed Launches Community Engagement Centres and Acquires Int...
8/31/2015Tweed Marijuana Inc. Completes Acquisition of bedrocan Canna...
8/28/2015Tweed Quarterly Conference Call Details
8/27/2015Bedrocan Receives Additional License Capacity from Health Ca...
8/24/2015Bedrocan Announces Shareholder Approval of Plan of Arrangeme...
8/24/2015Bedrocan Domestic Production Facility Is Fully-Licensed by H...
8/20/2015Tweed Commences Cannabis Extraction, Provides Corporate Upda...
7/28/2015Bedrocan Receives Health Canada Approval to Sell Domesticall...
7/8/2015Tweed Updates Oil Extraction Efforts and Latest Product Offe...
7/8/2015Abba Medix Builds a Diversified Business
4/8/2015Testing the Limits: DigiPath Labs Targets Booming Nevada MMJ...
4/2/2015Tweed Marijuana grants stock options
4/1/2015April 1 Alert: Tweed R&D Discovers Exciting Genetic Mutation
3/25/2015Tweed Marijuana Inc. Announces Partial Exercise of Over-Allo...
3/17/2015Tweed Marijuana Inc. Closes $20 Million Bought Deal Financin...
2/26/2015Tweed Marijuana Inc. Releases Full Q4 Financials and Provide...
2/23/2015Canadian regulators warn on medical marijuana disclosures
2/20/2015Tweed Installs Aeroponics Pilot Project with Indoor Harvest
2/18/2015Tweed Marijuana releases key fourth quarter summary and prov...
2/10/2015Tweed and Canabo Medical Corporation Launch Collaborative Re...
1/26/2015Cannabix Provides Alternative to Costly Drug Detection Tacti...
1/5/2015Tweed Marijuana Inc. announces second license renewal and ma...
12/12/2014Canadian medical marijuana company PharmaCan to go public ne...
12/11/2014Tweed Provides Support to The Canadian AIDS Society
11/26/2014Tweed Marijuana Inc. Q3 Results and Operational Highlights
11/20/2014Enertopia Provides Footage of Planned MMPR Facility
11/19/2014Tweed announces license renewal
8/16/2011(Block A)Begins 20,000 Metre Drill Program on Block A
7/29/2011Analysis on Trade Winds Ventures TWD: TSX.V - TWDIF: OTC fro...
5/2/2011(Block A)Completes Preliminary Metallurgical Study on Block A
2/21/2011(Block A)Named to 2011 TSX Venture Top 50 Companies - Ranked 9th in M...
11/21/2008' Thanks You for Attending Online Presentation
8/12/2008Company Update
7/16/2008To Begin Exploration on BC Projects
Comments closed
 
Latest comment posted for this article
Be the first to comment
Add your comment
TSX-V (TWD.V)Other OTC (TWDIF)
1.81-1.09%0.400+8.11%
TSX-V
CA$ 1.81
09/21 15:59 -0.020
-1.09%
Prev close Open
1.83 1.90
Low High
1.80 1.90
Year l/h YTD var.
 -  -
52 week l/h 52 week var.
- -  1.81 -%
Volume 1 month var.
203,340 -%
24hGold TrendPower© : -11
Produces
Develops
Explores for Copper - Gold
 
 
 
Analyse
Interactive chart Add to compare
Interactive
chart
Print Compare Export
Last updated on : 1/23/2010
You must be logged in to use the porfolio and watchlists (free)
Top Newsreleases
MOST READ
Annual variation
DateVariationHighLow
 
5 years chart
 
3 months chart
 
3 months volume chart
 
 
Mining Company News
Plymouth Minerals LTDPLH.AX
Plymouth Minerals Intersects Further High Grade Potash in Drilling at Banio Potash Project - Plannin
AU$ 0.12-8.00%Trend Power :
Santos(Ngas-Oil)STO.AX
announces expected non-cash impairment
AU$ 7.16+0.56%Trend Power :
Oceana Gold(Au)OGC.AX
RELEASES NEW TECHNICAL REPORT FOR THE HAILE GOLD MINE
AU$ 2.35-4.86%Trend Power :
Western Areas NL(Au-Ni-Pl)WSA.AX
Advance Notice - Full Year Results Conference Call
AU$ 3.86+0.00%Trend Power :
Canadian Zinc(Ag-Au-Cu)CZN.TO
Reports Financial Results for Q2 and Provides Project Updates
CA$ 0.12+4.55%Trend Power :
Stornoway Diamond(Gems-Au-Ur)SWY.TO
Second Quarter Results
CA$ 0.02+100.00%Trend Power :
McEwen Mining(Cu-Le-Zn)MUX
TO ACQUIRE BLACK FOX FROM PRIMERO=C2=A0
US$ 3.35+1.82%Trend Power :
Rentech(Coal-Ngas)RTK
Rentech Announces Results for Second Quarter 2017
US$ 0.20-12.28%Trend Power :
KEFIKEFI.L
Reduced Funding Requirement
GBX 0.59+0.51%Trend Power :
Lupaka Gold Corp.LPK.V
Lupaka Gold Receives First Tranche Under Amended Invicta Financing Agreement
CA$ 0.02+0.00%Trend Power :
Imperial(Ag-Au-Cu)III.TO
Closes Bridge Loan Financing
CA$ 2.72+1.49%Trend Power :
Guyana Goldfields(Cu-Zn-Pa)GUY.TO
Reports Second Quarter 2017 Results and Maintains Production Guidance
CA$ 1.84+0.00%Trend Power :
Lundin Mining(Ag-Au-Cu)LUN.TO
d Share Capital and Voting Rights for Lundin Mining
CA$ 7.26+1.82%Trend Power :
Canarc Res.(Au)CCM.TO
Canarc Reports High Grade Gold in Surface Rock Samples at Fondaway Canyon, Nevada
CA$ 0.28-5.08%Trend Power :
Havilah(Cu-Le-Zn)HAV.AX
Q A April 2017 Quarterly Report
AU$ 0.36+26.79%Trend Power :
Uranium Res.(Ur)URRE
Commences Lithium Exploration Drilling at the Columbus Basin Project
US$ 6.80-2.86%Trend Power :
Platinum Group Metals(Au-Cu-Gems)PTM.TO
Platinum Group Metals Ltd. Operational and Strategic Process ...
CA$ 2.08+3.48%Trend Power :
Devon Energy(Ngas-Oil)DVN
Announces $340 Million of Non-Core Asset Sales
US$ 65.26+1.24%Trend Power :
Precision Drilling(Oil)PD-UN.TO
Announces 2017Second Quarter Financial Results
CA$ 8.66-0.35%Trend Power :
Terramin(Ag-Au-Cu)TZN.AX
2nd Quarter Report
AU$ 0.03+0.00%Trend Power :